Global phase ii non-alcoholic steatohepatitis clinical trials market statistics, 2018-2030 (USD Million)
Global phase ii non-alcoholic steatohepatitis clinical trials market size was valued at 530.8 USD million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2030.